- Report
- February 2024
- 135 Pages
Asia Pacific
From €2632EUR$2,950USD£2,321GBP
- Report
- December 2023
- 133 Pages
Europe
From €1316EUR$1,475USD£1,160GBP
€2632EUR$2,950USD£2,321GBP
- Report
- August 2023
- 338 Pages
Global
From €2454EUR$2,750USD£2,164GBP
€4908EUR$5,500USD£4,327GBP
- Report
- April 2023
- 208 Pages
Global
From €2454EUR$2,750USD£2,164GBP
€4908EUR$5,500USD£4,327GBP
- Report
- March 2023
- 294 Pages
Global
From €2454EUR$2,750USD£2,164GBP
€4908EUR$5,500USD£4,327GBP
- Report
- January 2024
- 77 Pages
Global
From €2186EUR$2,450USD£1,928GBP
- Report
- October 2024
- 200 Pages
Global
From €3346EUR$3,750USD£2,950GBP
- Report
- May 2024
- 185 Pages
Global
From €4015EUR$4,500USD£3,540GBP
- Report
- July 2025
- 200 Pages
Vietnam
From €2489EUR$2,789USD£2,194GBP
- Report
- March 2024
- 123 Pages
Europe
From €1338EUR$1,500USD£1,180GBP
- Report
- January 2024
- 200 Pages
Global
From €3703EUR$4,150USD£3,265GBP
- Book
- September 2020
North America

The Artificial Intelligence In Cardiology market is a rapidly growing sector of the Artificial Intelligence industry. It is focused on the development of AI-based solutions to improve the diagnosis, treatment, and management of cardiovascular diseases. AI-based solutions are used to analyze medical images, detect anomalies, and provide personalized treatments. AI-based solutions are also used to monitor patient health, detect early signs of cardiovascular diseases, and provide personalized recommendations. AI-based solutions are also used to improve the accuracy of diagnosis and reduce the time and cost of treatment.
Some of the companies in the Artificial Intelligence In Cardiology market include IBM Watson Health, GE Healthcare, Siemens Healthineers, Philips Healthcare, and Medtronic. Show Less Read more